Genomic insights into cancer-associated aberrant CpG island hypermethylation

Duncan Sproul,Richard R Meehan,D. Sproul,R. R. Meehan

DOI: https://doi.org/10.1093/bfgp/els063

2013-01-21

Briefings in Functional Genomics

Abstract:Carcinogenesis is thought to occur through a combination of mutational and epimutational events that disrupt key pathways regulating cellular growth and division. The DNA methylomes of cancer cells can exhibit two striking differences from normal cells; a global reduction of DNA methylation levels and the aberrant hypermethylation of some sequences, particularly CpG islands (CGIs). This aberrant hypermethylation is often invoked as a mechanism causing the transcriptional inactivation of tumour suppressor genes that directly drives the carcinogenic process. Here, we review our current understanding of this phenomenon, focusing on how global analysis of cancer methylomes indicates that most affected CGI genes are already silenced prior to aberrant hypermethylation during cancer development. We also discuss how genome-scale analyses of both normal and cancer cells have refined our understanding of the elusive mechanism(s) that may underpin aberrant CGI hypermethylation.

genetics & heredity,biotechnology & applied microbiology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to understand the role of aberrant CpG island hypermethylation in cancer and its significance in the process of cancer development. Specifically, the paper explores the following aspects:

1. **Changes in DNA methylation in cancer**: The paper points out that, compared with normal cells, the DNA methylation patterns of cancer cells show two significant differences: a decrease in the overall DNA methylation level and aberrant hypermethylation of certain sequences (especially CpG islands). How these changes affect gene expression and cell function is one of the focuses of the research.

2. **The impact of aberrant hypermethylation on tumor suppressor genes**: Aberrant hypermethylation is generally considered to lead to the transcriptional inactivation of tumor suppressor genes (TSGs), thus directly driving the occurrence and development of cancer. The paper discusses this hypothesis in detail and provides relevant evidence to support it.

3. **Most aberrantly hypermethylated genes are already silenced in pre - cancerous cells**: Through large - scale analysis of the cancer methylome, the study found that most genes that are aberrantly hypermethylated in cancer are already silenced in pre - cancerous cells. This indicates that aberrant hypermethylation may be a secondary event rather than the initial cause of gene silencing.

4. **The driver and passenger models of epigenetic events in cancer**: The paper proposes a hypothesis that in cancer, the aberrant hypermethylation of a small number of active genes may act as "drivers", while the hypermethylation of most already - silenced genes acts as "passengers". This model helps to explain why the hypermethylation of certain genes is closely related to the occurrence and development of cancer.

5. **Other roles of aberrant CpG island hypermethylation**: The paper also explores other potential roles of aberrant CpG island hypermethylation in cancer, such as maintaining the stem - cell - like state of cancer cells or limiting the epigenetic plasticity that restricts cancer progression. These hypotheses provide a new perspective for understanding the complexity of epigenetic changes in cancer.

In summary, this paper aims to comprehensively analyze cancer methylome data to deeply explore the role of aberrant CpG island hypermethylation in the occurrence and development of cancer and the underlying molecular mechanisms.